Quality of Life in Japanese Patients with Dysmenorrhea Treated with Ethinylestradiol 20 μg/Drospirenone 3 mg in a Real-World Setting: An Observational Study

Quality of Life in Japanese Patients with Dysmenorrhea Treated with Ethinylestradiol 20 μg/Drospirenone 3 mg in a Real-World Setting: An Observational Study

Mikio Momoeda,1 Sayako Akiyama,2 Kota Tanaka,3 Yoshimi Suzukamo4 1Department of Integrated Women’s Health, St. Luke’s International Hospital, Tokyo, Japan; 2Market Access, Bayer Yakuhin, Ltd., Tokyo, Japan; 3Statistics Analysis Department 2, EPS Corporation, Osaka, Japan; 4Depart...

Full description

Bibliographic Details
Main Authors: Momoeda M, Akiyama S, Tanaka K, Suzukamo Y
Format: Article
Language:English
Published: Dove Medical Press 2020-05-01
Series:International Journal of Women's Health
Subjects:
patient-reported outcomes
sf-36
dysmenorrhea
quality of life
ethinylestradiol/drospirenone
japan
Online Access:https://www.dovepress.com/quality-of-life-in-japanese-patients-with-dysmenorrhea-treated-with-et-peer-reviewed-article-IJWH

Internet

https://www.dovepress.com/quality-of-life-in-japanese-patients-with-dysmenorrhea-treated-with-et-peer-reviewed-article-IJWH

Similar Items